VISTAGEN THERAPEUTICS, INC. (VTGN) Operating margin 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-5683.7%FY2026 · since FY2017: -819.9% → -5683.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -5683.7% | +5833.4 pp |
| FY2025 | -11517.1% | -8413.6 pp |
| FY2024 | -3103.5% | — |
| FY2022 | -4308.3% | -2662.2 pp |
| FY2021 | -1646.1% | — |
| FY2017 | -819.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VTGN financial trends
VTGN RevenueVTGN Net incomeVTGN Net marginVTGN Gross profitVTGN Gross marginVTGN Operating incomeVTGN Operating cash flowVTGN Free cash flowVTGN Capital expendituresVTGN Return on equityVTGN Stock buybacksVTGN Dividends paidVTGN Total assetsVTGN Total liabilitiesVTGN Shareholders’ equityVTGN overview →